Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Leases: 2023-2024

Historic Current Leases for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Dec 2024 value amounting to $792,000.

  • Maravai Lifesciences Holdings' Current Leases rose 23.38% to $876,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $876,000, marking a year-over-year increase of 23.38%. This contributed to the annual value of $792,000 for FY2024, which is 25.12% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Current Leases of $792,000 as of FY2024, which was up 25.12% from $633,000 recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Current Leases ranged from a high of $792,000 in FY2024 and a low of $633,000 during FY2023.
  • Moreover, its 2-year median value for Current Leases was $712,500 (2023), whereas its average is $712,500.
  • Data for Maravai Lifesciences Holdings' Current Leases shows a peak YoY rose of 25.12% (in 2024) over the last 5 years.
  • Maravai Lifesciences Holdings' Current Leases (Yearly) stood at $633,000 in 2023, then rose by 25.12% to $792,000 in 2024.